CHAMP App Feeding Difficulties Repository
Launched by CHILDREN'S MERCY HOSPITAL KANSAS CITY · Nov 10, 2023
Trial Information
Current as of July 23, 2025
Enrolling by invitation
Keywords
ClinConnect Summary
Around 25% of children are reported to have some degree of feeding issues of whom 3-10% have more severe feeding disorders1. Many of these feeding issues and difficulties can also lead to a need for supplemental nutrition in a child's diet due to the impact on growth. Those requiring supplemental nutrition may find themselves having to be fed using tube feedings (TF), which carries its own set of obstacles and factors to consider. While feeding problems have been estimated to occur in 25%-35% of children observed as exhibiting normal growth, that number may spike to 85% in those with GI-rel...
Gender
ALL
Eligibility criteria
- Inclusion Criteria:
- • Patients enrolling in this research repository must also be enrolled in an applicable study (STUDY00002775, STUDY00003221) wherein they have consented to use CHAMP App
- • Parent-Legally authorized representative can read one of the eleven languages that the CHAMP App is available in.
- Exclusion Criteria:
- • • All patients and parents/Legally authorized representative not meeting the above specified criteria
About Children's Mercy Hospital Kansas City
Children's Mercy Hospital Kansas City is a renowned pediatric healthcare institution dedicated to advancing the health and well-being of children through innovative research and clinical trials. As a leading sponsor of clinical trials, the hospital focuses on developing and testing new treatments and therapies that address a wide range of pediatric conditions. With a commitment to excellence in patient care and a collaborative approach to research, Children's Mercy is at the forefront of pediatric medicine, striving to improve outcomes and enhance the quality of life for children and their families.
Contacts
Jennifer Cobb
Immunology at National Institute of Allergy and Infectious Diseases (NIAID)
Locations
Kansas City, Missouri, United States
Patients applied
Trial Officials
Lori Erickson, PhD
Principal Investigator
Director, Remote Health Solutions Children's Mercy
Timeline
First submit
Trial launched
Trial updated
Estimated completion
Not reported